Crystal structure of sparsentan, C 32 H 40 N 4 O 5 S
Source abstract
Abstract
Abstract The crystal structure of sparsentan has been solved and refined using synchrotron X-ray powder diffraction data and optimized using density functional theory techniques. Sparsentan crystallizes in space group P-1 (#2) with a = 11.4214(8), b = 12.0045(9), c = 14.1245(12) Å, α = 97.6230(22), β = 112.4353(16), γ = 110.2502(11)°, V = 1599.20(6) Å 3 , and Z = 2 at 298 K. The crystal structure consists of an isotropic packing of dimers of sparsentan molecules, linked by N–H···O=S hydrogen bonds. Several intra- and intermolecular C–H···O and C–H···N hydrogen bonds also link the molecules. The powder pattern has been submitted to the International Centre for Diffraction Data for inclusion in the Powder Diffraction File ™ (PDF ® ).
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Magnetism in coordination complexes · Crystal structures of chemical compounds
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (35)
Show source-provided references
1. The Assignment and Validation of Metal Oxidation States in the Cambridge Structural Database10.1107/S0108768199015086 ↗
2. The Lower Energy Diffraction and Sattering Sde-Bounce Beamline for Materials Science at the Canadian Light Source10.1107/S1600577521002496 ↗
3. 10.1017/S088571562400015010.1017/S0885715624000150 ↗
4. Open Babel: An Open Chemical Toolbox
5. 10.1107/S160057672100291010.1107/S1600576721002910 ↗
6. Phenomenological Model of Anisotropic Peak Broadening in Powder Diffraction10.1107/S0021889898006001 ↗
7. New Software for Statistical Analysis of Cambridge Structural Database Data10.1107/S0021889811014622 ↗
8. 10.1002/anie.19951555110.1002/anie.199515551 ↗
9. Crystal Structures of Ammonium Citrates10.1017/S0885715618000829 ↗
10. Bravais · 1866
11. 10.1093/nar/gkac95610.1093/nar/gkac956 ↗
12. 10.1107/S160057671901409210.1107/S1600576719014092 ↗
13. 10.1063/1.46788210.1063/1.467882 ↗
14. 2023
15. A New Law of Crystal Morphology Etending the Law of Bravais
16. 10.1016/0927-0256(96)00008-010.1016/0927-0256(96)00008-0 ↗
17. 2024
18. Macikenas, D. , Ruby, K. , Hulvat, J. F. , and Wu, X. . 2022. Amorphous Sparsentan Compositions. U.S. Patent Application US 2022/0048900 A1.
19. 10.1021/acs.jctc.2c0095810.1021/acs.jctc.2c00958 ↗
20. 10.1107/S205252061600395410.1107/S2052520616003954 ↗
21. 10.1021/ar00172a00510.1021/ar00172a005 ↗
22. 10.1107/S002188980201523610.1107/S0021889802015236 ↗
23. 10.1017/S088571561400051710.1017/S0885715614000517 ↗
24. 10.1007/BF0054909610.1007/BF00549096 ↗
25. Consistent Gaussian Basis Sets of Triple-Zeta Valence with Polarization Quality for Solid-State Calculations10.1002/jcc.23153 ↗
26. Komers, R. , and Shih, A. . 2018. “Biphenyl Sulfonamide Compounds for the Treatment of Kidney Diseases or Disorders.” International Patent Application WO 2018/071784.
27. 2023
28. 10.3406/bulmi.1907.282010.3406/bulmi.1907.2820 ↗
29. 2023
30. 2024
31. Murugesan, N. , Tellew, J. E. , Macor, J. E. , and Gu, Z. . 2003. Biphenyl Sulfonamides as Dual Angiotensin Endothelin Receptor Antagonists. U.S. Patent 6638937 B2.
32. Murugesan, N. , Tellew, J. E. , Macor, J. E. , and Gu, Z. . 2000. Biphenyl Sulfonamides as Dual Angiotensin Endothelin Receptor Antagonists. International Patent Application 2000/01389 A1.
33. 10.1107/S002188981300353110.1107/S0021889813003531 ↗
34. Retrieval of Crystallographically-Derived Molecular Geometry Information10.1021/ci049780b ↗
35. 10.1107/S205252061402290210.1107/S2052520614022902 ↗